Atlas Trials

Proteomics/Modifier Based on Mass Spectrometry Reveals the Pathogenesis of Eclampsia During Pregnancy and the Screening of Disease Markers

Clinical trial NCT04833881 · UNKNOWN

Trial details

NCT number
NCT04833881
Sponsor
Heilongjiang University of Chinese Medicine
Status
UNKNOWN
Study type
OBSERVATIONAL
MechanismMarker Screening
Start date
2021-04-01
Primary completion
2024-11-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.